Champions Oncology Inc reports results for the quarter ended in October - Earnings Summary

Champions Oncology

12/12/2023 22:01

* Champions Oncology Inc  CSBR.OQ  reported a quarterly
adjusted
loss of 15 cents​​ per share for the quarter ended in October,
lower than the same quarter last year, when the company reported
breakeven earnings per share.  The mean expectation of
three analysts for the quarter was for a loss of 17 cents per
share. 
    * Revenue fell 19% to $11.57 million from a year ago;
analysts
expected $12.84 million. 
    * Champions Oncology Inc's reported EPS for the quarter was
a loss
of 15 cents​.
    * The company reported a quarterly loss of $2.07 million.
    * Champions Oncology Inc shares had fallen by 20.6% this
quarter and gained 9.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 142.9% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Champions
Oncology Inc is $8.75 
This summary was machine generated from LSEG data December 12 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Oct. 31 2023      -0.17          -0.15          Beat
 Jul. 31 2023      -0.10          -0.19          Missed
 Apr. 30 2023      -0.12          -0.19          Missed
 Jan. 31 2023      -0.03          -0.18          Missed